Simultaneous treatment of asthma and allergic rhinitis

Pediatric Pulmonology

Volumn 38, Issue 3, 2004, Pages 186-192

  Camargos, Paulo A M ^a   Rodrigues, Mary E S M ^a   Lasmar, Laura M L B F ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Municipal Health Authority   (Brazil)

Author keywords

Allergic rhinitis; Asthma; Inhaled corticosteroid; Treatment

Indexed keywords

BECLOMETASONE DIPROPIONATE;

ADOLESCENT; AEROSOL; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FACE MASK; FUNCTIONAL ASSESSMENT; HUMAN; INSPIRATORY CAPACITY; MAJOR CLINICAL STUDY; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; COMORBIDITY; FEMALE; HUMANS; MALE; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 4143138744     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.20084     Document Type: Article

References (25)

1. International Study of Asthma and Allergies in Childhood Steering Committee. Worldwide variations in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-1232.
2. Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:147-334.
3. Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax [Suppl] 2000;55:26-27.
4. National Institutes of Health. National Heart, Lung, and Blood Institute. Global initiative for asthma. Revised 2002. Bethesda: NIH Publication 02-3659.
5. Gibson GJ, Marbely DJ, Lal S, Ali MM, Butler AG. Double-blind cross-over trial comparing intranasal beclomethasone dipropionate and placebo in aerosol in perennial rhinitis. Br Med J 1974;4:503-504.
6. Shore SC, Weinberg EG. Beclomethasone dipropionate aerosol in treatment of perennial allergic rhinitis in children. Arch Dis Child 1977;52:486-488.
7. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995;332:868-875.
8. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992;146:547-554.
9. Pedersen B, Dahl R, Lindqvist N, Mygind N. Nasal inhalation of glucocorticoid budesonide from a spacer for treatment of patient with pollen rhinitis and asthma. Allergy 1990;45:451-456.
10. Pedersen W, Hjuler I, Dahl R, Mygind N. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma. Allergy 1998;53:383-387.
11. Lippmann M. Deposition and clearance of inhaled particles in the human nose. Ann Otol Rhinol Laryngol 1970;79:519-528.
12. Mygind N, Bisgaard H, Dahl R. Simultaneous treatment of rhinitis and asthma by nasal inhalation of corticosteroid from a spacer. Allergy [Suppl] 1999;54:132-135.
13. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2001;31:616-624.
14. Rosier MJ, Bishop J, Nolan T, Robertson CF, Carlin JB, Phelan PD. Measurement of functional severity of asthma in children. Am J Respir Crit Care Med 1994;149:1434-1441.
15. Holmström M, Scadding GK, Lund VJ, Darby YC. Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology 1990;28:191-196.
16. Wilson A, Dempsey OJ, Sims EJ, Coutie JR, Paterson MC, Lipworth BJ. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy 2000;30:833-838.
17. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia: W.B. Saunders; 1971.
18. American Thoracic Society. Standartization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
19. European Academy of Allergy and Clinical Immunology. Position paper: allergen standardization and skin tests. Allergy 1993;48:48-82.
20. Camargos P, Rubim J, Lasmar L. Beclomethasone dipropionate delivered through a new spacer developed in Brazil. Eur Respir J [Suppl] 2000;16:541.
21. Ates NB, Esposito-Festen JE, Tiddens HAWM, van der Mark TW. Asthma therapy for young children in developing countries: in search of a cost effective pMDI-spacer combination. Am J Respir Crit Care Med 2002;165:190.
22. Dean AG, Dean JA, Coulombier D, Burton AH, Brendel KA, Smith DC, et al. EpiInfo, version 6.04d: a word processing, database, and statistics program for public health on micro-computers. Atlanta: Centers for Disease Control and Prevention-World Health Organization; 2001.
23. Gleeson MJ, Youlten LJF, Shelton DM, Siodlak MZ, Eiser NM, Carol LW. Assessment of nasal airway patency: a comparison of four methods. Clin Otolaryngol 1986;11:99-107.
24. Wihl JA, Malm L. Rhinomanometry and nasal peak expiratrory and inspiratory flow rate. Ann Allergy 1998;61:50-55.
25. Watson JP, Lewis RA. Is asthma treatment affordable in developing countries? Thorax 1997;52:605-607.